Transport specificity of FpvA and FpvB for pyoverdine–antibiotic conjugates in Pseudomonas aeruginosa
Abstract
Pyoverdines (PVDs) are fluorescent siderophores produced by many Pseudomonas species. In P. aeruginosa, the TonB-dependent transporters (TBDT) FpvA and FpvB mediate PVD-dependent iron acquisition. PVDs have emerged as promising vectors for antibiotics in antibacterial Trojan horse strategies. However, the uptake of PVD-antibiotic conjugates by FpvA and FpvB remains poorly characterized. Here, we report the semisynthesis of a PVD–oxazolidine conjugate used as a molecular tool to investigate how P. aeruginosa accesses iron via these TBDTs in the presence of two native PVDs and their corresponding antibiotic conjugates. Growth assays demonstrate that P. aeruginosa can access iron chelated by PVDs through both FpvA and FpvB. In contrast, although both antibiotic conjugates provide iron to the strain via FpvA, only one does so via FpvB, indicating differential receptor recognition. Docking analyses reveal that native PVDs adopt similar binding modes within both FpvA and FpvB. However, FpvB—previously described as a broadly selective transporter—exhibits selective restriction toward PVD–antibiotic conjugates. Our results provide insights for the design of PVD-antibiotic conjugates and emphasize the critical role of the conjugation site on PVD in ensuring efficient transporter-mediated uptake.
Related
- WITHDRAWN: Evaluating phage-antibiotic synergy in differentiated primary airway epithelial cultures against Pseudomonas aeruginosa
- Pseudomonas aeruginosa evolves to an infection state of reduced virulence and enhanced survival during antibiotic selection in an airway tissue model
- Bacteriophage and Antibiotic Resistance Are Positively Associated across a Phylogenetically Diverse Set of Clinical Pseudomonas aeruginosa Isolates
- Restoring Antibiotic Sensitivity via Metabolic Pathway Manipulation in Pseudomonas aeruginosa
- CpxR-CpxS two-component system exacerbates development of antibiotic resistance in Pseudomonas aeruginosa
BibTeX
@article{revoltissot2026transport,
title = {{Transport specificity of FpvA and FpvB for pyoverdine–antibiotic conjugates in Pseudomonas aeruginosa}},
author = {Johan Revol-Tissot and Christine Cézard and Anne Forster and Hélène Puja and Françoise Hoegy and Isabelle Schalk and Gaëtan L.A. Mislin and Benjamin Bouvier and Coraline Rigouin},
journal = {Bioorganic and Medicinal Chemistry},
year = {2026},
month = jul,
doi = {10.1016/j.bmc.2026.118734},
url = {https://u-picardie.hal.science/hal-05670493v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Transport specificity of FpvA and FpvB for pyoverdine–antibiotic conjugates in Pseudomonas aeruginosa
AU - Johan Revol-Tissot
AU - Christine Cézard
AU - Anne Forster
AU - Hélène Puja
AU - Françoise Hoegy
AU - Isabelle Schalk
AU - Gaëtan L.A. Mislin
AU - Benjamin Bouvier
AU - Coraline Rigouin
PY - 2026
DA - 2026/07/02
JO - Bioorganic and Medicinal Chemistry
DO - 10.1016/j.bmc.2026.118734
UR - https://u-picardie.hal.science/hal-05670493v1
AB - Pyoverdines (PVDs) are fluorescent siderophores produced by many Pseudomonas species. In P. aeruginosa, the TonB-dependent transporters (TBDT) FpvA and FpvB mediate PVD-dependent iron acquisition. PVDs have emerged as promising vectors for antibiotics in antibacterial Trojan horse strategies. However, the uptake of PVD-antibiotic conjugates by FpvA and FpvB remains poorly characterized. Here, we report the semisynthesis of a PVD–oxazolidine conjugate used as a molecular tool to investigate how P. aeruginosa accesses iron via these TBDTs in the presence of two native PVDs and their corresponding antibiotic conjugates. Growth assays demonstrate that P. aeruginosa can access iron chelated by PVDs through both FpvA and FpvB. In contrast, although both antibiotic conjugates provide iron to the strain via FpvA, only one does so via FpvB, indicating differential receptor recognition. Docking analyses reveal that native PVDs adopt similar binding modes within both FpvA and FpvB. However, FpvB—previously described as a broadly selective transporter—exhibits selective restriction toward PVD–antibiotic conjugates. Our results provide insights for the design of PVD-antibiotic conjugates and emphasize the critical role of the conjugation site on PVD in ensuring efficient transporter-mediated uptake.
SN - 0968-0896
SN - 1464-3391
ER -